Ascent Industries Executive Shows Confidence with $50,000 Stock Purchase
Rhea-AI Filing Summary
Insider Trading Alert: Ravi Ramesh Srinivas, VP of Operations - Chemicals at Ascent Industries (ACNT), has increased his position by purchasing 4,000 shares of common stock on June 18, 2025. The shares were acquired at a weighted average price of $12.44 per share, with individual transaction prices ranging from $12.38 to $12.50.
Following this transaction, Srinivas now beneficially owns a total of 16,000 shares directly. The purchase demonstrates a significant insider investment of approximately $49,760. This Form 4 filing indicates increased insider confidence in the company's prospects.
- Transaction Type: Open market purchase
- Ownership Form: Direct ownership
- Filing Relationship: Officer (VP, Operations - Chemicals)
- No derivative securities were involved in this transaction
Positive
- VP of Operations - Chemicals purchased 4,000 shares at $12.44 average price, representing a 33% increase in holdings from 12,000 to 16,000 shares, demonstrating strong insider confidence
Negative
- None.
Insider Trade Summary
Net Buyer: 4,000 shares
Net Buy
1 txn
Insider
Srinivas Ravi Ramesh
Role
Insider
Bought
4,000 shs ($50K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 4,000 | $12.44 | $50K |
Holdings After Transaction:
Common Stock — 16,000 shares (Direct)
Footnotes (1)
- F1. The reported price in column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $12.38 to $12.50 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth within this footnote.
FAQ
What is Ravi Ramesh Srinivas's position at ACNT?
Ravi Ramesh Srinivas serves as VP, Operations - Chemicals at Ascent Industries Co. (ACNT).
Was this ACNT insider purchase made under a 10b5-1 trading plan?
No, the Form 4 filing does not indicate that this transaction was made pursuant to a Rule 10b5-1 trading plan, as the corresponding checkbox was not marked.
AI-generated analysis. How Rhea-AI works. Not financial advice.